Strategy for identification of a potential inherited leukemia predisposition in a 299 patient's cohort with tumor-only sequencing data.

Saved in:
Bibliographic Details
Title: Strategy for identification of a potential inherited leukemia predisposition in a 299 patient's cohort with tumor-only sequencing data.
Authors: Aguilera-Diaz A; Advanced Genomics Laboratory, Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Larrayoz MJ; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Palomino-Echeverría S; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Vazquez I; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Ariceta B; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Mañú A; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Blasco-Iturri Z; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Bernal Del Castillo T; Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Olivares Salaverri M; Hematology Department, Hospital Universitario de Galdakao, Galdakao, Spain., Olave Rubio MT; Hematology Department, Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain., Rifon-Roca J; Hematology Department, Clinica Universidad de Navarra (CUN), Pamplona, Spain., Alfonso-Pierola A; Hematology Department, Clinica Universidad de Navarra (CUN), Pamplona, Spain., Prosper F; Advanced Genomics Laboratory, Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Hematology Department, Clinica Universidad de Navarra (CUN), Pamplona, Spain., Fernandez-Mercado M; Advanced Genomics Laboratory, Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain. Electronic address: mfmercado@unav.es., Calasanz MJ; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain; Scientific Co-Director of CIMA LAB Diagnostics, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.
Source: Leukemia research [Leuk Res] 2020 Aug; Vol. 95, pp. 106386. Date of Electronic Publication: 2020 May 24.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first